Get started
Author

Yan Mao

Upregulation of collagen type X alpha 1 promotes the progress of triple‐negative breast cancer via Wnt/β‐catenin signaling
2024 · Jing Peng, Xiangping Liu, et al. · Molecular Carcinogenesis · 12
Prognostic value and distribution pattern of tumor infiltrating lymphocytes and their subsets in distant metastases of advanced breast cancer
2023 · Xin-yi Sun, Cheng-qin Wang, et al. · Clinical Breast Cancer · 10
PDF
Al18F-NOTA-HER2-BCH versus 18F-FDG PET/CT in evaluating newly diagnosed HER2-low breast cancer patients
2025 · Xiaoyi Guo, Xu Liang, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 7
Tumor-infiltrating lymphocytes provides recent survival information for early-stage HER2-low-positive breast cancer: a large cohort retrospective study
2023 · Teng Sun, Tong Wang, et al. · Frontiers in Oncology · 6
PDF
HNRNPC-Mediated m6A Epitranscriptomics Drives CD80-Dependent Tubular Dysfunction in Sepsis-Induced AKI
2025 · Chenxia Juan, Xiangling Zhao, et al. · Inflammation · 3
PDF
Patient with hormone receptor‑positive Her2‑negative metastatic breast cancer with visceral crisis with good response to abemaciclib and letrozole: A case report and review of the literature
2024 · Yongmei Wang, Xueqing Zou, et al. · Molecular and Clinical Oncology · 2
PDF
The impact of the HER2-low status on conditional survival in patients with breast cancer
2024 · Teng Ma, Changgen Liu, et al. · Therapeutic Advances in Medical Oncology · 2
A clinicopathological and spatial feature-based nomogram for individualized prediction of axillary lymph node involvement in breast cancer
2026 · Xin-Yi Fang, Chang-Gen Liu, et al. · World Journal of Surgical Oncology · 1
A multimodal cross-temporal fusion system for complementary evaluation of neoadjuvant chemotherapy in breast cancer
2026 · Xinyi Sun, Dezhen Wang, et al. · European Journal of Radiology
Prognostic value of dynamic changes in C‑reactive protein‑albumin ratio for patients with spontaneous intracerebral hemorrhage
2026 · Jia Li, Guo-Min Xie, et al. · Biomarkers in Medicine
A Prospective Head-to-Head Comparison of HER2-Targeted and 18F-FDG PET/CT for Detecting Axillary Lymph Node Metastases Among Newly Diagnosed HER2-Positive and HER2-Low Breast Cancer
2026 · Xinqi Huang, Xiaoyi Guo, et al. · Clinical Nuclear Medicine
Preliminary clinical validation of a novel integrated genomic and epigenomic liquid biopsy assay (SPIRAL) in breast cancer.
2026 · Jue Wang, Yan Mao, et al. · Journal of Clinical Oncology
Al18F-NOTA-HER2-BCH PET/MR for regional lymph node metastasis assessment in HER2-low and -positive breast cancer: a prospective study
2026 · Hongmin Yang, Xiaoyi Guo, et al. · European Journal of Nuclear Medicine and Molecular Imaging
Additional file 3 of Identification of RPGRIP1L as an instability-maintaining gene to drive tumor growth and PD-L1 expression via Hedgehog signaling in breast cancer
2026 · Lv, Meng, Liu, Yan’e, et al. · Figshare
Additional file 1 of Identification of RPGRIP1L as an instability-maintaining gene to drive tumor growth and PD-L1 expression via Hedgehog signaling in breast cancer
2026 · Lv, Meng, Liu, Yan’e, et al. · Figshare
Additional file 2 of Identification of RPGRIP1L as an instability-maintaining gene to drive tumor growth and PD-L1 expression via Hedgehog signaling in breast cancer
2026 · Lv, Meng, Liu, Yan’e, et al. · Figshare
Additional file 4 of Identification of RPGRIP1L as an instability-maintaining gene to drive tumor growth and PD-L1 expression via Hedgehog signaling in breast cancer
2026 · Lv, Meng, Liu, Yan’e, et al. · Figshare
Identification of RPGRIP1L as an instability-maintaining gene to drive tumor growth and PD-L1 expression via Hedgehog signaling in breast cancer
2026 · Lv, Meng, Liu, Yan’e, et al. · Figshare
Identification of RPGRIP1L as an instability-maintaining gene to drive tumor growth and PD-L1 expression via Hedgehog signaling in breast cancer
2025 · Meng Lv, Yan’e Liu, et al. · BMC Cancer
Causal relationship between hypertension and cancer: a two‐sample bidirectional Mendelian randomization study
2025 · Chenggong Zeng, Juanhua Zhu, et al. · Translational Cancer Research
WITHDRAWN: EIF4A3-regulated circGNAI2 inhibits the progression of triple-negative breast cancer by circGNAI2-miR-454-3p-VGLL4 axis
2023 · hongming song, Haibo Wang, et al. · Research Square
Tumor-infiltrating lymphocytes (TILs) as a new predictor of recent prognosis in luminal breast cancer: A large cohort retrospective study
2023 · Teng Sun, Tong Wang, et al. · Research Square
PDF
Neoadjuvant therapy for HER2-positive and negative simultaneous bilateral primary breast cancer
2022 · Yan MAO, Haibo WANG · Minerva Medica
Works count: 28
Citation count: 43
H-index: 4
I10-index: 2
Year
Topic
Type